PLUS THERAPEUTICS, Inc. Common Stock (PSTV) is a publicly traded Healthcare sector company. As of July 15, 2026, PSTV trades at $4.28 with a market cap of $28.71M and a P/E ratio of -14.71. PSTV moved +4.32% today. Year to date, PSTV is -66.58%; over the trailing twelve months it is -49.09%. Its 52-week range spans $2.90 to $57.75. Analyst consensus is strong buy with an average price target of $39.67. Rallies surfaces PSTV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest PSTV news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.28 |
| Market Cap | $28.71M |
| P/E Ratio | -14.71 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $57.75 |
| 52-Week Low | $2.90 |
| Volume | 360.68K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.21M |
| Net Income | $-22.39M |
| Gross Margin | 0.00% |
3 analysts cover PSTV: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.67.